HOME Top Market Reports In Vitro Diagnostics (IVD) Quality Controls Market by Application (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology) Source (Serum, Blood, Plasma Based Controls) Type (Instrument Specific & Third Party Controls) - Forecast to 2020

In Vitro Diagnostics (IVD) Quality Controls Market by Application (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology) Source (Serum, Blood, Plasma Based Controls) Type (Instrument Specific & Third Party Controls) - Forecast to 2020

By: marketsandmarkets.com
Publishing Date: March 2016
Report Code: MD 4180

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The global In Vitro Diagnostics Quality Controls products market is expected to reach USD 979.0 Million by 2020, at a CAGR of 3.6% from 2015 to 2020. Growth in this market is mainly driven by factors such as the increasing number of accredited clinical laboratories and growing adoption of third-party quality controls to ensure unbiased test results. Moreover, the increasing use of multi-analyte controls and rising focus of key players on emerging countries are expected to offer new growth opportunities for players operating in this market. However, uncertainty in reimbursement and lack of regulations are restraining the growth of this market.

The In Vitro Diagnostics Quality Controls market studied in this report is segmented based on product type, applications, manufacturer type, end users, and region. Based on manufacturer type, the market is segmented into instrument manufacturer controls and independent manufacturer controls. The independent manufacturer controls segment accounted for the largest share of the market in 2015, owing to the rising adoption and preference for third-party quality controls.

Based on source type, the IVD quality controls products market is segmented into whole-blood-based products, serum-based products, plasma-based products, urine-based products, and other source-based products. Serum-based quality control products are highly preferred by laboratories; this segment accounted for the largest share of the quality controls market in 2015 and it also expected to witness the highest growth in the coming years. The large share and high growth of this segment is majorly attributed to the greater stability and longer shelf life of serum-based products.

North America dominated the global In Vitro Diagnostics Quality Controls products market in 2015. The large share of this region can be attributed to greater accessibility to advanced technologies, quality healthcare infrastructure, established distribution channels, and presence of various leading market players in this region. However, the Asia-Pacific region is expected to witness the highest growth in the coming years.

The key players in this market are Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Randox Laboratories (U.K.), Roche Diagnostics Limited (Switzerland), Abbott Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Siemens Healthcare (Germany), and Sysmex Corporation (Japan).

To know about the assumptions considered for the study, download the pdf brochure

Stakeholders

  • IVD product manufacturers
  • Group purchasing organizations (GPOs)
  • OEM manufacturers
  • Pathologists and pathology laboratories
  • Distributors of IVD quality controls products
  • Hospitals and clinics
  • Healthcare institutions
  • Research institutes
  • Market research and consulting firms
  • Venture capitalists and investors

Scope of the Report

This research report categorizes the global In Vitro Diagnostics Quality Controls market based on type and region. Each market is comprehensively analyzed by region (North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa) to provide in-depth information on the global scenario.

This research report categorizes the global In Vitro Diagnostics Quality Controls market into the following segments:

IVD Quality Controls Products Market, By Type

  • Quality Control Products
    • Human Whole-blood-based
    • Human Serum-based
    • Human Plasma-based
    • Human Urine-based
    • Others
  • Data Management Solutions
  • Quality Assurance Services

IVD Quality Controls Market, By Application

  • Clinical Chemistry
  • Immunochemistry
  • Hematology
  • Molecular Diagnostics
  • Coagulation/Hemostasis
  • Microbiology
  • Others

IVD Quality Controls Market, By End User

  • Laboratories
  • Hospitals
  • Research and Academic Institutes
  • Others

IVD Quality Controls Market, By Manufacturer Type

  • Instrument Manufacturer Controls
  • Independent Manufacturer Controls
    • Third-party Controls
    • Instrument-specific Controls

    IVD Quality Controls Market, by Region

    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • France
      • U.K.
      • Italy
      • Spain
      • Rest of Europe (RoE)
    • Asia-Pacific (APAC)
      • Japan
      • China
      • India
      • Rest of Asia-Pacific (RoAPAC)
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America (RoLA)
      • Middle East and Africa

    Table of Contents

    1 Introduction (Page No. - 19)
        1.1 Objectives of the Study
        1.2 Market Definition
        1.3 Market Scope
               1.3.1 Markets Covered
               1.3.2 Years Considered for the Study
        1.4 Currency
        1.5 Limitations
        1.6 Stakeholders

    2 Research Methodology (Page No. - 23)
        2.1 Research Data
               2.1.1 Secondary Data
                        2.1.1.1 Key Data From Secondary Sources
               2.1.2 Primary Data
                        2.1.2.1 Key Data From Primary Sources
                        2.1.2.2 Key Industry Insights
        2.2 Market Size Estimation
        2.3 Market Breakdown and Data Triangulation
        2.4 Market Share Estimation
        2.5 Assumptions for the Study

    3 Executive Summary (Page No. - 30)

    4 Premium Insights (Page No. - 35)
        4.1 Growth Potential of the Market
        4.2 Asia-Pacific: Market
        4.3 IVD Quality Control Products Market: Geographic Snapshot
        4.4 Geographic Mix: IVD Quality Control Products Market
        4.5 IVD Quality Control Products Market: Emerging vs. Developed Markets

    5 Market Overview (Page No. - 40)
        5.1 Introduction
        5.2 Market Segmentation
               5.2.1 IVD Quality Control Products Market, By Type
               5.2.2 Market, By Application
               5.2.3 Market, By Manufacturer Type
               5.2.4 Market, By End User
        5.3 Market Dynamics
               5.3.1 Market Drivers
                        5.3.1.1 Growing Number of Accredited Clinical Laboratories
                        5.3.1.2 Increasing Adoption of Third-Party Quality Controls
               5.3.2 Market Restraints
                        5.3.2.1 Additional Cost Involved in Quality Control, Budget Constraints in Hospitals and Laboratories
                        5.3.2.2 Unfavorable Reimbursement Scenario in the IVD Industry
               5.3.3 Market Opportunity
                        5.3.3.1 Rising Demand for Multi-Analyte Controls
               5.3.4 Market Challenges
                        5.3.4.1 Stringent Product Approval Process
                        5.3.4.2 Lack of Proper Regulations and Non-Compliance to Regulations

    6 Industry Insights (Page No. - 49)
        6.1 Introduction
        6.2 Industry Trends
               6.2.1 Growing Adoption of Third-Party Quality Controls
               6.2.2 Increasing Focus of Customers Towards the Use of External Quality Assurance Support From Manufacturers
        6.3 Porter’s Five Force Analysis
               6.3.1 Threat of New Entrants
               6.3.2 Threat of Substitutes
               6.3.3 Bargaining Power of Suppliers
               6.3.4 Bargaining Power of Buyers
               6.3.5 Intensity of Competitive Rivalry
        6.4 Regulatory Analysis
               6.4.1 North America
                        6.4.1.1 U.S.
                        6.4.1.2 Canada
               6.4.2 Europe
               6.4.3 Asia-Pacific
                        6.4.3.1 Japan
                        6.4.3.2 China
                        6.4.3.3 India

    7 Global IVD Quality Controls Products Market, By Type (Page No. - 57)
        7.1 Introduction
        7.2 Quality Controls
               7.2.1 Whole-Blood-Based Controls
               7.2.2 Serum-Based Controls
               7.2.3 Plasma-Based Controls
               7.2.4 Urine-Based Controls
               7.2.5 Other IVD Quality Controls
        7.3 Data Management Solutions
        7.4 Quality Assurance Services

    8 Global IVD Quality Controls Market, By Application (Page No. - 69)
        8.1 Introduction
        8.2 Clinical Chemistry
        8.3 Immunochemistry
        8.4 Hematology
        8.5 Molecular Diagnostics
        8.6 Coagulation/Hemostasis
        8.7 Microbiology
        8.8 Others

    9 Global IVD Quality Controls Market, By End User (Page No. - 80)
        9.1 Introduction
        9.2 Hospitals
        9.3 Clinical Laboratories
        9.4 Research and Academic Institutes
        9.5 Others

    10 IVD Quality Controls Market, By Manufacturer Type (Page No. - 87)
         10.1 Introduction
         10.2 Instrument Manufacturer Controls
         10.3 Independent Manufacturer Controls
                  10.3.1 Third-Party Controls
                  10.3.2 Instrument-Specific Controls

    11 Geographic Analysis (Page No. - 94)
         11.1 Introduction
         11.2 North America
                  11.2.1 U.S.
                  11.2.2 Canada
         11.3 Europe
                  11.3.1 Germany
                  11.3.2 France
                  11.3.3 U.K.
                  11.3.4 Italy
                  11.3.5 Spain
                  11.3.6 Rest of Europe (RoE)
         11.4 Asia-Pacific (APAC)
                  11.4.1 Japan
                  11.4.2 China
                  11.4.3 India
                  11.4.4 Rest of Asia-Pacific (RoAPAC)
         11.5 Latin America
                  11.5.1 Brazil
                  11.5.2 Mexico
                  11.5.3 Rest of Latin America (RoLA)
         11.6 Middle East and Africa

    12 Company Profiles (Page No. - 156)
         12.1 Abbott Diagnostics
         12.2 Bio-Rad Laboratories, Inc.
         12.3 Roche Diagnostics
         12.4 Thermo Fisher Scientific, Inc.
         12.5 Randox Laboratories Ltd.
         12.6 Helena Laboratories
         12.7 Sero as
         12.8 Seracare Life Sciences, Inc.
         12.9 Technopath Clinical Diagnostics
         12.10 Sun Diagnostics, LLC.
         12.11 Siemens Healthcare
         12.12 Sysmex Corporation
         12.13 Danaher Corporation
         12.14 Ortho Clinical Diagnostics, Inc.

    *Details on Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured in Case of Unlisted Companies.

    13 Competitive Landscape (Page No. - 192)
         13.1 Overview
         13.2 Market Share Analysis
         13.3 Competitive Situation and Trends
         13.4 New Product Launches
         13.5 Agreements, Partnerships, and Collaborations
         13.6 Mergers and Acquisitions
         13.7 Expansions

    14 Appendix (Page No. - 200)
         14.1 Insights of Industry Experts
         14.2 Discussion Guide
         14.3 Other Developments, January 2012–January 2016
         14.4 Introducing RT: Real-Time Market Intelligence
         14.5 Available Customizations
         14.6 Related Reports


    List of Tables (144 Tables)

    Table 1 Market Drivers: Impact Analysis
    Table 2 Market Restraints: Impact Analysis
    Table 3 Market Opportunities: Impact Analysis
    Table 4 In Vitro Diagnostics Quality Controls Market Challenges: Impact Analysis
    Table 5 Accreditation Bodies for Quality Systems for Medical Laboratories in Europe
    Table 6 Products Market Size, By Type,2013–2020 (USD Million)
    Table 7 Global In Vitro Diagnostics Quality Controls Market Size, By Source Type,2013–2020 (USD Million)
    Table 8 Global In Vitro Diagnostics Quality Controls Market Size, By Country,2013–2020 (USD Million)
    Table 9 Global Whole-Blood-Based Quality Controls Market Size, By Country, 2013–2020 (USD Million)
    Table 10 Global Serum-Based Quality Controls Market Size, By Country, 2013–2020 (USD Million)
    Table 11 Global Plasma-Based Quality Controls Market Size, By Country, 2013–2020 (USD Million)
    Table 12 Global Urine-Based Quality Controls Market Size, By Country, 2013–2020 (USD Million)
    Table 13 Global Other Market Size, By Country, 2013–2020 (USD Million)
    Table 14 Global In Vitro Diagnostics Quality Controls Data Management Solutions Market Size, By Country, 2013–2020 (USD Million)
    Table 15 Global IVD Quality Assurance Services Market Size, By Country, 2013–2020 (USD Million)
    Table 16 Global IVD Quality Controls Market Size, By Application, 2013–2020 (USD Million)
    Table 17 Global IVD Quality Controls Market Size for Clinical Chemistry, By Country, 2013–2020 (USD Million)
    Table 18 Global Market Size for Immunochemistry, By Country, 2013–2020 (USD Million)
    Table 19 Global Market Size for Hematology, By Country, 2013–2020 (USD Million)
    Table 20 Global Market Size for Molecular Diagnostics, By Country, 2013–2020 (USD Million)
    Table 21 Global Market Size for Coagulation and Hemostasis, By Country, 2013–2020 (USD Million)
    Table 22 Global Market Size for Microbiology, By Country, 2013–2020 (USD Million)
    Table 23 Global Quality Controls Market Size for Other Applications, By Country, 2013–2020 (USD Million)
    Table 24 Global Market Size, By End User, 2013–2020 (USD Million)
    Table 25 Global Market Size for Hospitals, By Country, 2013–2020 (USD Million)
    Table 26 Global Market Size for Clinical Laboratories, By Country, 2013–2020 (USD Million)
    Table 27 Global Market Size for Research and Academic Institutes, By Country, 2013–2020 (USD Million)
    Table 28 Global Market Size for Other End Users, By Country, 2013–2020 (USD Million)
    Table 29 Global Market Size, By Manufacturer Type, 2013–2020 (USD Million)
    Table 30 Global Instrument Manufacturer Controls Market Size, By Country, 2013–2020 (USD Million)
    Table 31 Global Independent Manufacturer Controls Market Size, By Type, 2013–2020 (USD Million)
    Table 32 Global Independent Manufacturer Controls Market Size, By Country, 2013–2020 (USD Million)
    Table 33 Global Third-Party Quality Controls Market Size, By Country, 2013–2020 (USD Million)
    Table 34 Global Instrument-Specific Controls Market Size, By Country, 2013–2020 (USD Million)
    Table 35 Global Products Market Size, By Region, 2013–2020 (USD Million)
    Table 36 Global Products Market Size, By Country, 2013–2020 (USD Million)
    Table 37 North America: Products Market Size, By Country, 2013–2020 (USD Million)
    Table 38 North America: Products Market Size, By Type, 2013–2020 (USD Million)
    Table 39 North America: In Vitro Diagnostics Quality Controls Market Size, By Source Type, 2013–2020 (USD Million)
    Table 40 North America: In Vitro Diagnostics Quality Controls Market Size, By Application, 2013–2020 (USD Million)
    Table 41 North America: In Vitro Diagnostics Quality Controls Market Size, By End User, 2013–2020 (USD Million)
    Table 42 North America: IVD Quality Controls Market Size, By Manufacturer Type, 2013–2020 (USD Million)
    Table 43 U.S.: Products Market Size, By Type, 2013–2020 (USD Million)
    Table 44 U.S.: Market Size, By Source Type, 2013–2020 (USD Million)
    Table 45 U.S.: Market Size, By Application, 2013–2020 (USD Million)
    Table 46 U.S.: Market Size, By End User,2013–2020 (USD Million)
    Table 47 U.S.: Market Size, By Manufacturer Type, 2013–2020 (USD Million)
    Table 48 Canada: IVD Quality Control Products Market Size, By Type, 2013–2020 (USD Million)
    Table 49 Canada: Market Size, By Source Type, 2013–2020 (USD Million)
    Table 50 Canada: Market Size, By Application, 2013–2020 (USD Million)
    Table 51 Canada: Market Size, By End User, 2013–2020 (USD Million)
    Table 52 Canada: Market Size, By Manufacturer Type, 2013–2020 (USD Million)
    Table 53 Europe: Products Market Size, By Country, 2013–2020 (USD Million)
    Table 54 Europe: Products Market Size, By Type, 2013–2020 (USD Million)
    Table 55 Europe: Market Size, By Source Type, 2013–2020 (USD Million)
    Table 56 Europe: Market Size, By Application, 2013–2020 (USD Million)
    Table 57 Europe: Market Size, By End User, 2013–2020 (USD Million)
    Table 58 Europe: Market Size, By Manufacturer Type, 2013–2020 (USD Million)
    Table 59 Germany: Products Market Size, By Type, 2013–2020 (USD Million)
    Table 60 Germany: IVD Quality Controls Market Size, By Source Type, 2013–2020 (USD Million)
    Table 61 Germany: Market Size, By Application, 2013–2020 (USD Million)
    Table 62 Germany: Market Size, By End User, 2013–2020 (USD Million)
    Table 63 Germany: Market Size, By Manufacturer Type, 2013–2020 (USD Million)
    Table 64 France: Products Market Size, By Type, 2013–2020 (USD Million)
    Table 65 France: IVD Quality Controls Market Size, By Source Type, 2013–2020 (USD Million)
    Table 66 France: Market Size, By Application, 2013–2020 (USD Million)
    Table 67 France: Market Size, By End User, 2013–2020 (USD Million)
    Table 68 France: Market Size, By Manufacturer Type, 2013–2020 (USD Million)
    Table 69 U.K.: IVD Quality Controls Products Market Size, By Type, 2013–2020 (USD Million)
    Table 70 U.K.: Market Size, By Source Type, 2013–2020 (USD Million)
    Table 71 U.K.: Market Size, By Application, 2013–2020 (USD Million)
    Table 72 U.K.: Market Size, By End User, 2013–2020 (USD Million)
    Table 73 U.K.: Market Size, By Manufacturer Type, 2013–2020 (USD Million)
    Table 74 Italy: IVD Quality Controls Products Market Size, By Type, 2013–2020 (USD Million)
    Table 75 Italy: Market Size, By Source Type, 2013–2020 (USD Million)
    Table 76 Italy: Market Size, By Application, 2013–2020 (USD Million)
    Table 77 Italy: Market Size, By End User,2013–2020 (USD Million)
    Table 78 Italy: Market Size, By Manufacturer Type, 2013–2020 (USD Million)
    Table 79 Spain: IVD Quality Controls Products Market Size, By Type, 2013–2020 (USD Million)
    Table 80 Spain: Market Size, By Source Type, 2013–2020 (USD Million)
    Table 81 Spain: Market Size, By Application, 2013–2020 (USD Million)
    Table 82 Spain: Market Size, By End User,2013–2020 (USD Million)
    Table 83 Spain: Market Size, By Manufacturer Type, 2013–2020 (USD Million)
    Table 84 RoE: IVD Quality Controls Products Market Size, By Type, 2013–2020 (USD Million)
    Table 85 RoE: Market Size, By Source Type, 2013–2020 (USD Million)
    Table 86 RoE: Market Size, By Application, 2013–2020 (USD Million)
    Table 87 RoE: Market Size, By End User,2013–2020 (USD Million)
    Table 88 RoE: Market Size, By Manufacturer Type, 2013–2020 (USD Million)
    Table 89 APAC: IVD Quality Controls Products Market Size, By Country, 2013–2020 (USD Million)
    Table 90 APAC: IVD Quality Controls Products Market Size, By Type, 2013–2020 (USD Million)
    Table 91 APAC: Market Size, By Source Type, 2013–2020 (USD Million)
    Table 92 APAC: Market Size, By Application, 2013–2020 (USD Million)
    Table 93 APAC: Market Size, By End User,2013–2020 (USD Million)
    Table 94 APAC: Market Size, By Manufacturer Type, 2013–2020 (USD Million)
    Table 95 Japan: Products Market Size, By Type,2013–2020 (USD Million)
    Table 96 Japan: IVD Quality Controls Market Size, By Source Type, 2013–2020 (USD Million)
    Table 97 Japan: Market Size, By Application, 2013–2020 (USD Million)
    Table 98 Japan: Market Size, By End User,2013–2020 (USD Million)
    Table 99 Japan: Market Size, By Manufacturer Type, 2013–2020 (USD Million)
    Table 100 China: Products Market Size, By Type, 2013–2020 (USD Million)
    Table 101 China: IVD Quality Controls Market Size, By Source Type, 2013–2020 (USD Million)
    Table 102 China: In Vitro Diagnostics Quality Controls Market Size, By Application, 2013–2020 (USD Million)
    Table 103 China: Market Size, By End User,2013–2020 (USD Million)
    Table 104 China: In Vitro Diagnostics Quality Controls Market Size, By Manufacturer Type, 2013–2020 (USD Million)
    Table 105 India: Products Market Size, By Type, 2013–2020 (USD Million)
    Table 106 India: In Vitro Diagnostics Quality Controls Market Size, By Source Type, 2013–2020 (USD Million)
    Table 107 India: In Vitro Diagnostics Quality Controls Market Size, By Application, 2013–2020 (USD Million)
    Table 108 India: In Vitro Diagnostics Quality Controls Market Size, By End User,2013–2020 (USD Million)
    Table 109 India: In Vitro Diagnostics Quality Controls Market Size, By Manufacturer Type, 2013–2020 (USD Million)
    Table 110 RoAPAC: Products Market Size, By Type, 2013–2020 (USD Million)
    Table 111 RoAPAC: IVD Quality Controls Market Size, By Source Type, 2013–2020 (USD Million)
    Table 112 RoAPAC: Market Size, By Application, 2013–2020 (USD Million)
    Table 113 RoAPAC: Market Size, By End User, 2013–2020 (USD Million)
    Table 114 RoAPAC: Market Size, By Manufacturer Type, 2013–2020 (USD Million)
    Table 115 Latin America: Products Market Size, By Country, 2013–2020 (USD Million)
    Table 116 Latin America: IVD Quality Controls Products Market Size, By Type, 2013–2020 (USD Million)
    Table 117 Latin America: Market Size, By Source Type, 2013–2020 (USD Million)
    Table 118 Latin America: Market Size, By Application, 2013–2020 (USD Million)
    Table 119 Latin America: Market Size, By End User, 2013–2020 (USD Million)
    Table 120 Latin America: Market Size, By Manufacturer Type, 2013–2020 (USD Million)
    Table 121 Brazil: IVD Quality Control Products Market Size, By Type, 2013–2020 (USD Million)
    Table 122 Brazil: Market Size, By Source Type, 2013–2020 (USD Million)
    Table 123 Brazil: Market Size, By Application, 2013–2020 (USD Million)
    Table 124 Brazil: Products Market Size, By End User, 2013–2020 (USD Million)
    Table 125 Brazil: Products Market Size, By Manufacturer Type, 2013–2020 (USD Million)
    Table 126 Mexico: IVD Quality Controls Products Market Size, By Type, 2013–2020 (USD Million)
    Table 127 Mexico: In Vitro Diagnostics Quality Controls Market Size, By Source Type, 2013–2020 (USD Million)
    Table 128 Mexico: IVD Quality Controls Market Size, By Application, 2013–2020 (USD Million)
    Table 129 Mexico: IVD Quality Controls Market Size, By End User, 2013–2020 (USD Million)
    Table 130 Mexico: Market Size, By Manufacturer Type, 2013–2020 (USD Million)
    Table 131 RoLA: IVD Quality Controls Products Market Size, By Type, 2013–2020 (USD Million)
    Table 132 RoLA: Market Size, By Source Type, 2013–2020 (USD Million)
    Table 133 RoLA: Market Size, By Application, 2013–2020 (USD Million)
    Table 134 RoLA: Market Size, By End User,2013–2020 (USD Million)
    Table 135 RoLA: Market Size, By Manufacturer Type, 2013–2020 (USD Million)
    Table 136 Middle East and Africa: IVD Quality Controls Products Market Size, By Type, 2013–2020 (USD Million)
    Table 137 Middle East and Africa: Market Size, By Source Type, 2013–2020 (USD Million)
    Table 138 Middle East and Africa: Market Size, By Application, 2013–2020 (USD Million)
    Table 139 Middle East and Africa: Market Size, By End User, 2013–2020 (USD Million)
    Table 140 Middle East and Africa: Market Size, By Manufacturer Type, 2013–2020 (USD Million)
    Table 141 New Product Launches, January 2012–January 2016
    Table 142 Agreements, Partnerships, and Collaborations, January 2012–January 2016
    Table 143 Mergers and Acquisitions, January 2012–January 2016
    Table 144 Expansions, January 2012–January 2016
     
     
    List of Figures (41 Figures)

     
    Figure 1 Global IVD Quality Controls Products Market
    Figure 2 Research Design
    Figure 3 Bottom-Up Approach
    Figure 4 Top-Down Approach
    Figure 5 Data Triangulation Methodology
    Figure 6 Global IVD Quality Controls Products Market Size, By Type, 2015 vs. 2020 (USD Million)
    Figure 7 Global In Vitro Diagnostics Quality Controls Market Size, By Manufacturer Type,2015 vs. 2020 (USD Million)
    Figure 8 Global In Vitro Diagnostics Quality Controls Market Size, By End User, 2015 vs. 2020 (USD Million)
    Figure 9 Global In Vitro Diagnostics Quality Controls Market Size, By Application, 2015 vs. 2020 (USD Million)
    Figure 10 In Vitro Diagnostics Quality Controls Market: Geographic Snapshot
    Figure 11 Increasing Number of Accredited Laboratories is Driving the Growth of the In Vitro Diagnostics Quality Controls Market
    Figure 12 Serum-Based Controls to Account for the Largest Share of the In Vitro Diagnostics Quality Controls Market in Asia-Pacific
    Figure 13 U.S. to Command Almost Half of the Global In Vitro Diagnostics Quality Controls Market
    Figure 14 North America to Dominate the In Vitro Diagnostics Quality Controls Market During the Forecast Period
    Figure 15 Emerging Markets Estimated to Grow at the Highest Rate During the Forecast Period
    Figure 16 Products Market, By Type
    Figure 17 Market, By Application
    Figure 18 Market, By Manufacturer Type
    Figure 19 In Vitro Diagnostics Quality ControlsMarket, By End User
    Figure 20 In Vitro Diagnostics Quality Controls Market: Drivers, Restraints, Opportunities, & Challenges
    Figure 21 Number of Accredited Medical Laboratories in Europe, 2011-2014
    Figure 22 Number of Accredited Medical Laboratories in Japan, Australia, India, and Canada: June-2011-March 2015
    Figure 23 Quality Controls Segment to Witness the Highest Growth During the Forecast Period
    Figure 24 Molecular Diagnostics Will Grow at the Highest CAGR During the Forecast Period of 2015-2020
    Figure 25 Clinical Laboratories is the Fastest Growing End-User Segment of the Market During the Forecast Period
    Figure 26 Independent Manufacturer Controls Segment to Witness Highest Growth During the Forecast Period
    Figure 27 North America to Dominate the v Products Market
    Figure 28 North America Market Snapshot
    Figure 29 Europe Market Snapshot
    Figure 30 Accredited Clinical Laboratories in Mexico: 2005-2015
    Figure 31 Geographic Revenue Mix of the Top 5 Market Players
    Figure 32 Company Snapshot: Abbott Laboratories, Inc.
    Figure 33 Company Snapshot: Bio-Rad Laboratories, Inc.
    Figure 34 Company Snapshot: F. Hoffmann-La Roche Ltd.
    Figure 35 Company Snapshot: Thermo Fisher Scientific, Inc.
    Figure 36 Company Snapshot: Siemens AG
    Figure 37 Company Snapshot: Sysmex Corporation
    Figure 38 Company Snapshot: Danaher Corporation
    Figure 39 Players Majorly Adopted the Strategy of New Product Launches From January 2012 to January 2016
    Figure 40 Global in Vitro Diagnostics Quality Control Products Market Share Analysis, By Key Player, 2014
    Figure 41 Battle for Market Share: New Product Launches Was the Key Strategy 

    The global in vitro diagnostics quality control products market is estimated to reach USD 979.0 Million by 2020, growing at a CAGR of 3.6% during the forecast period of 2015 to 2020. This market is mainly driven by the growing number of accredited clinical laboratories across the globe and rising need to ensure the accuracy and reliability of diagnostic test results.

    In this report, the IVD Quality Controls market is segmented based on product type, applications, manufacturer type, end users, and region. This research report discusses key market drivers, restraints, opportunities, and challenges in the global In Vitro Diagnostics Quality Controls market and its submarkets.

    Based on product type, the market is segmented into quality controls, data management solutions, and quality assurance services. The quality controls segment accounted for the largest share of the In Vitro Diagnostics Quality Controls products market, by type, in 2015; it is also expected to grow at the highest CAGR during the forecast period of 2015 to 2020. The large share of this segment is mainly attributed to the increasing availability & demand for technologically advanced quality control materials with greater stability. The growing number of accredited clinical laboratories and mandates on these laboratories to perform quality control tests is driving the growth of the In Vitro Diagnostics Quality Controls market.

    Based on applications, the IVD quality controls market is segmented into the clinical chemistry, immunochemistry, hematology, molecular diagnostics, coagulation/hemostasis, microbiology, and other applications. The immunochemistry segment accounted for the largest share of the In Vitro Diagnostics Quality Controls market in 2015. The large share of this segment can be attributed to the increasing number of multi-analyte controls to perform immunoassay tests. However, the molecular diagnostics segment is the fastest-growing segment in the In Vitro Diagnostics Quality Controls applications market, mainly due to the increasing number of molecular diagnostic tests performed in laboratories and the rising need to ensure the accuracy of these complex diagnostic tests.

    In 2015, North America represented the largest regional market for IVD quality controls, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Although North America will continue to dominate the global In Vitro Diagnostics Quality Controls market during the forecast period, the Asia-Pacific region is expected to be the fastest-growing geographic market in the coming years. A majority of the growth in this region is driven by the rapid increase in the number of accredited laboratories and increasing use of quality control products by clinical laboratories in this region.

    The major players in the global In Vitro Diagnostics Quality Controls market are Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Randox Laboratories (U.K.), Roche Diagnostics Limited (Switzerland), Abbott Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Siemens Healthcare (Germany), and Sysmex Corporation (Japan).

    To speak to our analyst for a discussion on the above findings, click Speak to Analyst

    Custom Market Research Services

    We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

    Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

    Connect With Us

    Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
    Live Chat Support


    US : 1-888-600-6441
    UK : 44-800-368-9399

    Search reports



    Access reports on all high
    growth Medical Devices Markets on KnowledgeStore
    Request Demo